U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Entropion

MedGen UID:
41813
Concept ID:
C0014390
Disease or Syndrome
Synonym: Entropions
SNOMED CT: Eyelid inverted (33168009); Eyelashes turned in (33168009); Eyelid turned in (33168009); Entropion of eyelid (33168009); Folded in eyelid (33168009); Entropion (33168009)
 
HPO: HP:0000621
Monarch Initiative: MONDO:0001519

Definition

An abnormal inversion (turning inward) of the eyelid (usually the lower) towards the globe. Entropion is usually acquired as a result of involutional or cicatricial processes but may occasionally be congenital. [from HPO]

Conditions with this feature

DE SANCTIS-CACCHIONE SYNDROME
MedGen UID:
75550
Concept ID:
C0265201
Disease or Syndrome
A rare autosomal recessive inherited syndrome. It is characterized by xeroderma pigmentosum, mental retardation, dwarfism, hypogonadism, and neurologic abnormalities.
Xeroderma pigmentosum group A
MedGen UID:
82775
Concept ID:
C0268135
Disease or Syndrome
Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).
Xeroderma pigmentosum, group D
MedGen UID:
75656
Concept ID:
C0268138
Disease or Syndrome
Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).
Neonatal pseudo-hydrocephalic progeroid syndrome
MedGen UID:
140806
Concept ID:
C0406586
Disease or Syndrome
Wiedemann-Rautenstrauch syndrome (WDRTS) is a rare autosomal recessive neonatal progeroid disorder characterized by intrauterine growth retardation, failure to thrive, short stature, a progeroid appearance, hypotonia, and variable mental impairment (summary by Toriello, 1990). Average survival in WDRTS is 7 months, although survival into the third decade of life has been reported (Akawi et al., 2013).
Xeroderma pigmentosum variant type
MedGen UID:
376352
Concept ID:
C1848410
Disease or Syndrome
Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).
Xeroderma pigmentosum, group E
MedGen UID:
341219
Concept ID:
C1848411
Congenital Abnormality
Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).
Ectodermal dysplasia, sensorineural hearing loss, and distinctive facial features
MedGen UID:
355878
Concept ID:
C1864966
Disease or Syndrome
Tricho-oculo-dermo-vertebral syndrome
MedGen UID:
355714
Concept ID:
C1866427
Disease or Syndrome
Xeroderma pigmentosum, group C
MedGen UID:
416702
Concept ID:
C2752147
Disease or Syndrome
Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).
Isolated microphthalmia 8
MedGen UID:
767438
Concept ID:
C3554524
Disease or Syndrome
Any isolated microphthalmia in which the cause of the disease is a mutation in the ALDH1A3 gene.
Meier-Gorlin syndrome 6
MedGen UID:
905079
Concept ID:
C4225188
Disease or Syndrome
Any Meier-Gorlin syndrome in which the cause of the disease is a mutation in the GMNN gene.
Autosomal recessive cutis laxa type 2C
MedGen UID:
1385755
Concept ID:
C4479387
Disease or Syndrome
Autosomal recessive cutis laxa type IIC (ARCL2C) is characterized by generalized skin wrinkling with sparse subcutaneous fat and dysmorphic progeroid facial features. Most patients also exhibit severe hypotonia as well as cardiovascular involvement (summary by Van Damme et al., 2017). For a general phenotypic description and a discussion of genetic heterogeneity of autosomal recessive cutis laxa, see ARCL1A (219100).
Autosomal recessive cutis laxa type 2D
MedGen UID:
1376619
Concept ID:
C4479409
Disease or Syndrome
Autosomal recessive cutis laxa type IID (ARCL2D) is characterized by generalized skin wrinkling with sparse subcutaneous fat and dysmorphic progeroid facial features. Most patients also exhibit severe hypotonia as well as cardiovascular and neurologic involvement (summary by Van Damme et al., 2017). For a general phenotypic description and a discussion of genetic heterogeneity of autosomal recessive cutis laxa, see ARCL1A (219100).
Restrictive dermopathy 1
MedGen UID:
1812447
Concept ID:
C5676878
Disease or Syndrome
A restrictive dermopathy that has material basis in homozygous or compound heterozygous mutation in the ZMPSTE24 gene on chromosome 1p34.

Professional guidelines

PubMed

Lin P, Kitaguchi Y, Mupas-Uy J, Sabundayo MS, Takahashi Y, Kakizaki H
Int Ophthalmol 2019 Aug;39(8):1895-1907. Epub 2018 Oct 12 doi: 10.1007/s10792-018-1004-1. PMID: 30315389
Damasceno RW, Avgitidou G, Belfort R Jr, Dantas PE, Holbach LM, Heindl LM
Arq Bras Oftalmol 2015 Sep-Oct;78(5):328-31. doi: 10.5935/0004-2749.20150087. PMID: 26466237
Carter SR
Am Fam Physician 1998 Jun;57(11):2695-702. PMID: 9636333

Recent clinical studies

Etiology

Chan D, Sokoya M, Ducic Y
Facial Plast Surg 2017 Dec;33(6):598-605. Epub 2017 Dec 1 doi: 10.1055/s-0037-1608711. PMID: 29195240
Hintschich C
Dev Ophthalmol 2008;41:85-102. doi: 10.1159/000131075. PMID: 18453763
Solomon A, Mabey D
BMJ Clin Evid 2007 Nov 7;2007 PMID: 19450349Free PMC Article
Alfano C, Chiummariello S, De Gado F, Bistoni G, Scuderi N
Acta Chir Plast 2006;48(3):85-8. PMID: 17165595
al-Towerki AA
Int Ophthalmol 1995-1996;19(5):287-91. doi: 10.1007/BF00130923. PMID: 8864812

Diagnosis

Chambers CB, Moe KS
Facial Plast Surg Clin North Am 2017 Feb;25(1):25-36. doi: 10.1016/j.fsc.2016.08.007. PMID: 27888891
Taylor HR, Burton MJ, Haddad D, West S, Wright H
Lancet 2014 Dec 13;384(9960):2142-52. Epub 2014 Jul 17 doi: 10.1016/S0140-6736(13)62182-0. PMID: 25043452
Fea A, Turco D, Actis AG, De Sanctis U, Actis G, Grignolo FM
Minerva Chir 2013 Dec;68(6 Suppl 1):27-35. PMID: 24172761
Ferreira IS, Bernardes TF, Bonfioli AA
Semin Ophthalmol 2010 May;25(3):66-71. doi: 10.3109/08820538.2010.488580. PMID: 20590415
Vallabhanath P, Carter SR
Curr Opin Ophthalmol 2000 Oct;11(5):345-51. doi: 10.1097/00055735-200010000-00010. PMID: 11148701

Therapy

Hakim F, Phelps PO
Dis Mon 2020 Oct;66(10):101039. Epub 2020 Jun 29 doi: 10.1016/j.disamonth.2020.101039. PMID: 32616300
Chambers CB, Moe KS
Facial Plast Surg Clin North Am 2017 Feb;25(1):25-36. doi: 10.1016/j.fsc.2016.08.007. PMID: 27888891
Carruthers J, Carruthers A
Clin Dermatol 2004 Jan-Feb;22(1):89-93. doi: 10.1016/j.clindermatol.2003.11.013. PMID: 15158551
Holsclaw DS
Int Ophthalmol Clin 1998 Fall;38(4):89-106. doi: 10.1097/00004397-199803840-00009. PMID: 10200078
Mondino BJ
Ophthalmology 1990 Jul;97(7):939-52. doi: 10.1016/s0161-6420(90)32479-x. PMID: 2199891

Prognosis

Chan D, Sokoya M, Ducic Y
Facial Plast Surg 2017 Dec;33(6):598-605. Epub 2017 Dec 1 doi: 10.1055/s-0037-1608711. PMID: 29195240
Taban M, Nakra T, Hwang C, Hoenig JA, Douglas RS, Shorr N, Goldberg RA
Ophthalmic Plast Reconstr Surg 2010 May-Jun;26(3):190-4. doi: 10.1097/IOP.0b013e3181baa23f. PMID: 20489545
Kakizaki H, Malhotra R, Madge SN, Selva D
Ann Plast Surg 2009 Sep;63(3):344-51. doi: 10.1097/SAP.0b013e31818c4b22. PMID: 19602948
Faraj HG, Hoang-Xuan T
Curr Opin Ophthalmol 2001 Aug;12(4):250-7. doi: 10.1097/00055735-200108000-00003. PMID: 11507337
Holsclaw DS
Int Ophthalmol Clin 1998 Fall;38(4):89-106. doi: 10.1097/00004397-199803840-00009. PMID: 10200078

Clinical prediction guides

Woźniak-Roszkowska E, Iljin A, Noszczyk B, Antoszewski B
Pol Przegl Chir 2023 Oct 17;96(2):50-58. doi: 10.5604/01.3001.0053.9352. PMID: 38629275
Çiftçi MD, Korkmaz İ, Palamar M, Yaman B, Eğrilmez S, Yağcı A, Akalın T, Barut Selver Ö
Turk J Ophthalmol 2023 Apr 20;53(2):79-84. doi: 10.4274/tjo.galenos.2022.34683. PMID: 37089009Free PMC Article
Han J, Lee SH, Shin HJ
Medicine (Baltimore) 2019 Aug;98(33):e16731. doi: 10.1097/MD.0000000000016731. PMID: 31415368Free PMC Article
Nemoto H, Togo T, Maruyama N, Miyabe K, Nakae S, Sumiya N
J Plast Reconstr Aesthet Surg 2017 Jul;70(7):946-951. Epub 2017 Feb 17 doi: 10.1016/j.bjps.2017.01.017. PMID: 28268157
Solomon A, Mabey D
BMJ Clin Evid 2007 Nov 7;2007 PMID: 19450349Free PMC Article

Recent systematic reviews

Al-Moraissi EA, Thaller SR, Ellis E
J Craniomaxillofac Surg 2017 Oct;45(10):1647-1654. Epub 2017 Jul 19 doi: 10.1016/j.jcms.2017.07.004. PMID: 28823598
Burton M, Habtamu E, Ho D, Gower EW
Cochrane Database Syst Rev 2015 Nov 13;2015(11):CD004008. doi: 10.1002/14651858.CD004008.pub3. PMID: 26568232Free PMC Article
Boboridis KG, Bunce C
Cochrane Database Syst Rev 2011 Dec 7;(12):CD002221. doi: 10.1002/14651858.CD002221.pub2. PMID: 22161369
Solomon A, Mabey D
BMJ Clin Evid 2007 Nov 7;2007 PMID: 19450349Free PMC Article
Yorston D, Mabey D, Hatt S, Burton M
Cochrane Database Syst Rev 2006 Jul 19;(3):CD004008. doi: 10.1002/14651858.CD004008.pub2. PMID: 16856026

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...